This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Hold Brighthouse Financial (BHF) Stock
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher alternative investment income, well diversified, high-quality portfolio and solid performances by the Annuities, Life and Run-off segments.
Zacks Industry Outlook Highlights Reinsurance Group of America, Voya Financial and American Equity Investment Life Holding
by Zacks Equity Research
Reinsurance Group of America, Voya Financial and American Equity Investment Life Holding are part of the Zacks Industry Outlook article.
Should Invesco S&P MidCap 400 Pure Value ETF (RFV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RFV
Lincoln National (LNC) Ties Up to Boost Variable Annuity Business
by Zacks Equity Research
Lincoln National (LNC) collaborates with the asset management subsidiary of JPMorgan so that it can benefit from the portfolio management capabilities of the latter and better serve its clients.
3 Stocks to Watch From the Prospering Life Insurance Industry
by Tanuka De
Redesigning and repricing of products and services as well as a rising rate environment will help life insurers like RGA, VOYA and AEL as they invest heavily in digitization.
Lincoln National's (LNC) Marketplace to Lower Student Loan Debt
by Zacks Equity Research
Lincoln National (LNC) unveils a financial wellness marketplace that will guide Americans in bringing down student loan debt from 2023 and subsequently, bolster its benefit and protection offering suite.
Lincoln National (LNC) Pauses Buybacks to Recover Q3 Loss
by Zacks Equity Research
Lincoln National (LNC) puts share buybacks on temporary hold to regain financial strength as well as cope with the substantial losses incurred in the third quarter of 2022.
Zacks.com featured highlights United Therapeutics, StoneCo, Reinsurance Group of America and United Airlines
by Zacks Equity Research
United Therapeutics, StoneCo, Reinsurance Group of America and United Airlines have been highlighted in this Screen of The Week article.
All You Need to Know About Reinsurance Group (RGA) Rating Upgrade to Buy
by Zacks Equity Research
Reinsurance Group (RGA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
4 Stocks With Upgraded Broker Ratings for Attractive Returns
by Swayta Shah
As brokers have a deeper insight into stocks, one must follow rating upgrades before investing. We select United Therapeutics (UTHR), StoneCo (STNE), Reinsurance Group of America (RGA) and United Airlines (UAL), as these have seen rating upgrades.
Why Reinsurance Group (RGA) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Higher Interest Rates? 3 Insurance Stocks to Consider
by Derek Lewis
With the Fed fully committed to bringing inflation down, stocks in the financial sector, such as insurers, may see their profit margins expand in higher interest-rate environments.
Reinsurance Group (RGA) Gains 28% YTD: More Upside Left?
by Zacks Equity Research
Better pricing and expanding business in the pension risk transfer market, solid in-force business ensuring predictable long-term earnings and effective capital deployment continue to drive Reinsurance Group (RGA).
Here's Why Reinsurance Group (RGA) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Manulife (MFC) Q3 Earnings Lag Estimates on Soft Asia Business
by Zacks Equity Research
Manulife's (MFC) Q3 results reflect solid sales volumes and favorable margins in the Canada and U.S. segments, and higher sales of equity and fixed income mandates, offset by lower new business gains.
American Equity (AEL) Q3 Earnings Top Estimates, Decrease Y/Y
by Zacks Equity Research
American Equity's (AEL) Q3 results reflect higher annuity product charges, increased net investment income and lower expenses, offset by lower premiums and other considerations.
Brighthouse (BHF) Q3 Earnings & Revenues Miss, Fall Y/Y
by Zacks Equity Research
Brighthouse Financial's (BHF) Q3 results reflect lower premiums, higher expenses and lower adjusted net investment income.
Reinsurance Group (RGA) Q3 Earnings Top, Revenues Rise Y/Y
by Zacks Equity Research
Reinsurance Group's (RGA) Q3 results reflect solid performance in the Asia/Pacific, Europe, Middle East and Africa (EMEA) and the U.S. and Latin America segments, offset by soft results in Canada.
Reinsurance Group (RGA) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Reinsurance Group (RGA) delivered earnings and revenue surprises of 76.87% and 4.98%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
BRP Group (BRP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BRP Group (BRP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reinsurance Group (RGA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Reinsurance Group (RGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights MetLife, Prudential Financial, Reinsurance Group of America, Marsh & McLennan Companies and Aflac
by Zacks Equity Research
MetLife, Prudential Financial, Reinsurance Group of America, Marsh & McLennan Companies and Aflac are included in this Analyst Blog.
5 Insurers Set to Outshine Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help MET, PRU, RGA, MMC, and AFL outperform Q3 earnings estimates.
Is a Beat in Store for Marsh & McLennan (MMC) in Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to reflect revenue and earnings growth owing to solid performances by its Risk and Insurance Services, and Consulting segments.
Reasons Why You Should Hold Reinsurance Group (RGA) Stock
by Zacks Equity Research
Reinsurance Group (RGA) is set to benefit from solid segmental performance, sufficient liquidity as well as prudent capital deployment.